New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease

There is clear, early noradrenergic dysfunction in Alzheimer's disease. This is likely secondary to pathological tau deposition in the locus coeruleus, the pontine nucleus that produces and releases noradrenaline, prior to involvement of cortical brain regions. Disruption of noradrenergic pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Michael, Malhotra, Paresh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994981/
https://www.ncbi.nlm.nih.gov/pubmed/35293158
http://dx.doi.org/10.1002/acn3.51539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994981/
https://www.ncbi.nlm.nih.gov/pubmed/35293158
http://dx.doi.org/10.1002/acn3.51539

Ejemplares similares